HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.

Abstract
Mice are used as models for western equine encephalitis virus (WEEV) infection, but high mortality is generally only seen with intracranial or intranasal challenge, while peripheral inoculation results in approximately 50% mortality and is not dose-dependent. Hamsters were therefore studied as a model for WEEV infection. Hamsters were highly sensitive to intraperitoneal (i.p.) infection with WEEV. Disease progression was rapid, and virus titers in serum, brain, liver, and kidney of infected hamsters peaked between 2 and 4 days post-virus inoculation (dpi). Foci of virus infection were detected in neurons of the cerebral cortex and midbrain. Pre-treatment i.p. with either interferon alfacon-1 (5 microg/kg/day) or with Ampligen (3.2 mg/kg/day) resulted in complete survival, reduced brain titers, and improved weight gain. This model of WEEV infection in hamsters appears to serve as a suitable model for the evaluation of potential therapeutic agents for the treatment of WEE disease.
AuthorsJustin G Julander, Venkatraman Siddharthan, Lawrence M Blatt, Kristiina Schafer, Robert W Sidwell, John D Morrey
JournalVirology (Virology) Vol. 360 Issue 2 Pg. 454-60 (Apr 10 2007) ISSN: 0042-6822 [Print] United States
PMID17118420 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antiviral Agents
  • Interferon Inducers
  • Interferon Type I
  • Interferon-alpha
  • Recombinant Proteins
  • Poly U
  • interferon alfacon-1
  • poly(I).poly(c12,U)
  • Poly I-C
Topics
  • Animals
  • Antiviral Agents (therapeutic use)
  • Body Weight
  • Brain (virology)
  • Cerebral Cortex (virology)
  • Cricetinae
  • Disease Models, Animal
  • Encephalitis Virus, Western Equine (drug effects, growth & development)
  • Encephalomyelitis, Equine (drug therapy, pathology, virology)
  • Interferon Inducers (therapeutic use)
  • Interferon Type I (therapeutic use)
  • Interferon-alpha
  • Kidney (virology)
  • Liver (virology)
  • Mesencephalon (virology)
  • Mesocricetus
  • Poly I-C (therapeutic use)
  • Poly U (therapeutic use)
  • Recombinant Proteins
  • Serum (virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: